IRIS Accounts Production v24.3.0.553 14712436 director 7.3.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147124362023-03-06147124362024-03-31147124362023-03-072024-03-31147124362023-03-0614712436ns15:EnglandWales2023-03-072024-03-3114712436ns14:PoundSterling2023-03-072024-03-3114712436ns10:Director12023-03-072024-03-3114712436ns10:PrivateLimitedCompanyLtd2023-03-072024-03-3114712436ns10:SmallEntities2023-03-072024-03-3114712436ns10:AuditExempt-NoAccountantsReport2023-03-072024-03-3114712436ns10:SmallCompaniesRegimeForDirectorsReport2023-03-072024-03-3114712436ns10:SmallCompaniesRegimeForAccounts2023-03-072024-03-3114712436ns10:FullAccounts2023-03-072024-03-3114712436ns10:RegisteredOffice2023-03-072024-03-3114712436ns5:CurrentFinancialInstruments2024-03-3114712436ns5:ShareCapital2024-03-3114712436ns5:RetainedEarningsAccumulatedLosses2024-03-3114712436ns5:PlantMachinery2023-03-072024-03-3114712436ns5:PlantMachinery2024-03-3114712436ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-31
REGISTERED NUMBER: 14712436 (England and Wales)















Financial Statements for the Period 7 March 2023 to 31 March 2024

for

Botulinum Central Suppliers UK Ltd

Botulinum Central Suppliers UK Ltd (Registered number: 14712436)






Contents of the Financial Statements
for the Period 7 March 2023 to 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Botulinum Central Suppliers UK Ltd

Company Information
for the Period 7 March 2023 to 31 March 2024







DIRECTOR: Ms N J Terrett





REGISTERED OFFICE: Babs Park
Blind Lane
Bourne End
Buckinghamshire
SL8 5LF





REGISTERED NUMBER: 14712436 (England and Wales)





ACCOUNTANTS: Graeme Bruce & Partners LLP
940 Green Lanes
London
N21 2AD

Botulinum Central Suppliers UK Ltd (Registered number: 14712436)

Balance Sheet
31 March 2024

Notes £    £   
FIXED ASSETS
Tangible assets 4 439,375

CURRENT ASSETS
Stocks 1,362,422
Debtors 5 143,234
Cash at bank 9,237
1,514,893
CREDITORS
Amounts falling due within one year 6 2,047,834
NET CURRENT LIABILITIES (532,941 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(93,566

)

CAPITAL AND RESERVES
Called up share capital 1
Retained earnings (93,567 )
(93,566 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 3 December 2024 and were signed by:



Ms N J Terrett - Director


Botulinum Central Suppliers UK Ltd (Registered number: 14712436)

Notes to the Financial Statements
for the Period 7 March 2023 to 31 March 2024

1. STATUTORY INFORMATION

Botulinum Central Suppliers UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 462,500
At 31 March 2024 462,500
DEPRECIATION
Charge for period 23,125
At 31 March 2024 23,125
NET BOOK VALUE
At 31 March 2024 439,375

Botulinum Central Suppliers UK Ltd (Registered number: 14712436)

Notes to the Financial Statements - continued
for the Period 7 March 2023 to 31 March 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 143,234

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 998,399
Other creditors 1,049,435
2,047,834